Samsrita Labs Limited (BOM:539267)

Market Cap	416.32M +21.3%
Revenue (ttm)	n/a
Net Income	-47.57M
EPS	-0.37
Shares Out	22.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	373
Average Volume	1,852
Open	18.30
Previous Close	18.30
Day's Range	18.30 - 18.35
52-Week Range	12.19 - 26.04
Beta	0.09
RSI	45.37
Earnings Date	Jan 30, 2026

About Samsrita Labs

Samsrita Labs Limited operates as a biopharmaceutical company in India. The company offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. It is also involved in the stem cell research a...

• Industry: Commercial Physical and Biological Research
• Founded: 1996
• Employees: 4
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539267